Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimization strategy for emergency tracheal intubation in out-of-hospital adults
2022-002686-15Phase 4Active
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Aug 2022
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of rocuronium, Sugammadex and succinylcholine (2 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Started Aug 2022; status: active.
02
Drugs
rocuroniumSugammadexsuccinylcholine
Beyond the preview
Go deeper on 2022-002686-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-002686-15.